EntreMed, Inc. (ENMD) - Financial and Strategic SWOT Analysis Review

Date: May 15, 2014
Pages: 39
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: E252638B140EN
Leaflet:

Download PDF Leaflet

EntreMed, Inc. (ENMD) - Financial and Strategic SWOT Analysis Review
EntreMed, Inc. (ENMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief Summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

EntreMed, Inc. (EntreMed) is a clinical-stage pharmaceutical company. It develops therapeutics for the treatment of cancer and inflammatory diseases. The company's lead compound, ENMD-2076, a selective angiogenic kinase inhibitor, has completed several Phase 1 studies in solid tumors, multiple myeloma and leukemia, and is conducting a multi-center Phase 2 study in ovarian cancer. EntreMed's other products in development include 2ME2 (2-methoxyestradiol) and MKC-1.

EntreMed, Inc. Key Recent Developments

Mar 21, 2014: EntreMed Reports 2013 Fourth Quarter And Full Year Financial Results
Nov 14, 2013: EntreMed Reports Third Quarter 2013 Financial Results
Aug 14, 2013: EntreMed Reports Second Quarter 2013 Financial Results
May 15, 2013: EntreMed Reports Q1 2013 Results
Apr 05, 2013: EntreMed Appoints Ken Ren As CEO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

EntreMed, Inc. - Key Facts
EntreMed, Inc. - Key Employees
EntreMed, Inc. - Key Employee Biographies
EntreMed, Inc. - Major Products and Services
EntreMed, Inc. - Pharmaceutical Pipeline Products Data
EntreMed, Inc., Pipeline Products by Therapy Area
EntreMed, Inc., Pipeline Products by Development Phase
EntreMed, Inc. - History
EntreMed, Inc. - Company Statement
EntreMed, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

EntreMed, Inc. - Business Description
EntreMed, Inc. - SWOT Analysis
SWOT Analysis - Overview
EntreMed, Inc. - Strengths
Strength - Strong liquidity
Strength - Focused Research and Development Activities
Strength - Strong Patent Portfolio
EntreMed, Inc. - Weaknesses
Weakness - Reliance on Third Parties
EntreMed, Inc. - Opportunities
Opportunity - Changing Demographics
Opportunity - Market Potential: Oncology
Opportunity - Orphan Drug Designation
EntreMed, Inc. - Threats
Threat - Stringent Governmental Regulations
Threat - Uncertain R&D Outcomes
Threat - Intense Competition
EntreMed, Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

EntreMed, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
EntreMed, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
EntreMed, Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

EntreMed, Inc., Recent Developments
Mar 21, 2014: EntreMed Reports 2013 Fourth Quarter And Full Year Financial Results
Nov 14, 2013: EntreMed Reports Third Quarter 2013 Financial Results
Aug 14, 2013: EntreMed Reports Second Quarter 2013 Financial Results
May 15, 2013: EntreMed Reports Q1 2013 Results
Apr 05, 2013: EntreMed Appoints Ken Ren As CEO
Mar 21, 2013: EntreMed Reports 2012 Results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

EntreMed, Inc., Key Facts
EntreMed, Inc., Key Employees
EntreMed, Inc., Key Employee Biographies
EntreMed, Inc., Major Products and Services
EntreMed, Inc., Number of Pipeline Products by Therapy Area
EntreMed, Inc., Number of Pipeline Products by Development Stage
EntreMed, Inc., Pipeline Products By Therapy Area and Development Phase
EntreMed, Inc., History
EntreMed, Inc., Subsidiaries
EntreMed, Inc., Key Competitors
EntreMed, Inc., Ratios based on current share price
EntreMed, Inc., Annual Ratios
EntreMed, Inc., Interim Ratios
EntreMed, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
EntreMed, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
EntreMed, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

EntreMed, Inc., Pipeline Products by Therapy Area
EntreMed, Inc., Pipeline Products by Development Phase
EntreMed, Inc., Performance Chart (2009 - 2013)
EntreMed, Inc., Ratio Charts
EntreMed, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
EntreMed, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Skip to top


Ask Your Question

EntreMed, Inc. (ENMD) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: